Pressroom

Pressroom: Press Releases

2010

New Targeted Therapy for Advanced Melanoma Associated with 80 Percent Response Rate

A multicenter study has concluded that treatment with a new targeted therapy called PLX4032 (also called RG7204) resulted in significant tumor shrinkage in 80 percent of patients with advanced melanoma. Investigators at Memorial Sloan-Kettering Cancer Center and colleagues at other cancer centers have published their findings in the August 26 edition of the New England Journal of Medicine.

August 25, 2010
Craig Thompson Named President of Memorial Sloan-Kettering Cancer Center

Craig B. Thompson, MD, has been named the new President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center effective November 2, 2010. His appointment concludes a search that began in January 2010.

August 10, 2010
Newly Developed Prediction Tool Helps Estimate Local Recurrence in Patients with Non-invasive Breast Cancer

The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. In an attempt to help physicians and patients weigh the risks and benefits of the available options, researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) are reporting in the Journal of Clinical Oncology on the development of a new prediction tool that calculates a patient’s individualized risk for recurrence five and ten years after surgery.

July 13, 2010
New Cancer Diagnostic and Treatment Facility Opens

Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC’s new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary setting designed to foster rapid innovations in cancer care.

July 7, 2010
Large-Scale Genomic Analysis of Prostate Cancer Unveiled

A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. The study, published in the journal Cancer Cell, provides a previously unavailable genomic analysis whose scope and size offers new insight leading to more effective diagnostic tests as well as future treatment options for prostate cancer patients.

June 24, 2010
Sergio Giralt Named Chief of the Adult Bone Marrow Transplantation Service at Memorial Sloan-Kettering

Sergio Giralt, MD, has been appointed Chief of the Adult Bone Marrow Transplantation Service in the Division of Hematologic Oncology in the Department of Medicine at Memorial Sloan-Kettering Cancer Center.

June 1, 2010
Martin S. Tallman Named Chief of the Leukemia Service in the Department of Medicine

Martin S. Tallman, MD, has been appointed Chief of the Leukemia Service in the Department of Medicine at Memorial Sloan-Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College.

May 11, 2010
New Chair of the Department of Pathology Appointed

Boris C. Bastian, MD, has been named Chair of the Department of Pathology at Memorial Sloan-Kettering Cancer Center. Dr. Bastian is also the incumbent of the James Ewing Alumni Chair of Pathology, and he will hold a joint appointment in the Center’s Human Oncology and Pathogenesis Program.

April 23, 2010
New Targeted Therapy Effective in Treating Advanced Prostate Cancer

An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer, known for its poor prognosis and limited treatment options.

April 14, 2010
Harold Varmus to Step Down as President of Memorial Sloan-Kettering Cancer Center

Harold Varmus, the president of Memorial Sloan-Kettering Cancer Center (MSKCC) since the start of 2000, announced today that he has asked the MSKCC Boards of Overseers and Managers to begin a search for his successor.

January 12, 2010

2009

Self-Seeding of Cancer Cells May Play a Critical Role in Tumor Progression

Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan-Kettering Cancer Center shows that circulating tumor cells - cancer cells that break away from a primary tumor and disseminate to other areas of the body - can also return to and grow in their tumor of origin, a newly discovered process called “self-seeding.”

December 24, 2009
Prostate Cancer Surgery Often Performed by Surgeons with Little Experience

A new study from researchers at Memorial Sloan-Kettering Cancer Center has found that the majority of surgeons treating prostate cancer in the United States have extremely low annual caseloads, potentially leading to increased rates of both surgical complications and cancer recurrence.

November 18, 2009
Cancer Patients and Doctors Report Drug Side Effects Differently, but When Combined Improve Reporting of Adverse Effects, Study Shows

In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information. A new longitudinal study from researchers at Memorial Sloan-Kettering Cancer Center finds that while clinicians’ and patients’ reporting of treatment side effects are very different from each other, together they provide a more complete, clinically meaningful picture of the treatment experience.

November 16, 2009
Study Examines Mastectomy and Breast-Conserving Surgery Rates

There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer. New data from an observational study published in the October 14 issue of the Journal of the American Medical Association, a theme issue on surgical care, found that breast-conserving surgery was presented and provided in the majority of patients evaluated.

October 13, 2009
New Evelyn H. Lauder Breast Center and MSKCC Imaging Center Opens

The new Evelyn H. Lauder Breast Center of Memorial Sloan-Kettering Cancer Center and the Memorial Sloan-Kettering Cancer Center Imaging Center have opened, offering patients the most advanced outpatient services for cancer diagnosis and breast cancer treatment and detection.

October 5, 2009
Paul Marks Prize Recognizes Three Young Cancer Researchers

Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of this year’s Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan-Kettering Cancer Center.

September 29, 2009
Charles Sawyers Honored with 2009 Lasker~DeBakey Clinical Medical Research Award

Memorial Sloan-Kettering Cancer Center physician-scientist Charles L. Sawyers has been named a recipient of the 2009 Lasker~DeBakey Award for Clinical Medical Research.

September 14, 2009
In the Modern Post-PSA Era, Prostate Cancer Surgery May Not be Necessary for Some Patients

Investigators at Memorial Sloan-Kettering Cancer Center, along with collaborating teams at the Cleveland Clinic and the University of Michigan, have completed the first large-scale, multi-institutional study of prostate cancer death after standard treatment to remove the prostate since PSA screening has become widely used as a method to screen for the disease.

July 27, 2009
Researchers Find Genetic Key to Breast Cancer's Ability to Survive and Spread

New research led by investigators at Memorial Sloan-Kettering Cancer Center sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.

July 6, 2009
Research Reveals What Drives Lung Cancer's Spread

A new study by researchers at Memorial Sloan-Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.

July 2, 2009
Syndicate content